Want to see IT:EUK full AI Analyst Report?
EUK Stock Chart & Stats
€0.72
-€0.02(-2.41%)
At close: 4:00 PM EST
€0.72
-€0.02(-2.41%)
Day’s Range― - ―
52-Week Range€0.45 - €0.82
Previous CloseN/A
Volume1.70K
Average Volume (3M)4.68K
Market Cap
€13.08M
Enterprise Value€142.65M
Total Cash (Recent Filing)€416.00K
Total Debt (Recent Filing)€128.29M
Price to Earnings (P/E)―
Beta0.28
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding22,741,629
10 Day Avg. Volume3,064
30 Day Avg. Volume4,678
Financial Highlights & Ratios
PEG Ratio-0.50
Price to Book (P/B)0.55
Price to Sales (P/S)0.31
P/FCF Ratio36.77
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Consistent Operating Cash FlowConsistent positive operating cash flow over multiple years shows the core care services generate real cash despite accounting losses. This provides a durable liquidity buffer to fund operations, service debt short-term, and support continuity while management addresses profitability and capital structure.
Resilient Operating MarginsRelatively steady EBIT and high EBITDA margins indicate the operating model generates underlying profitability from service delivery. These margins provide structural earnings power that can support recovery to net profitability if non-operating pressures (interest, one-offs) are managed over the medium term.
Service-contract-driven Revenue ModelA business built on contracted care services and reimbursements ties revenue to demographic and public health spending trends. That creates relatively predictable, recurring cash flows and structural demand, as aging populations and public-sector funding tend to sustain need for long-term care services over years.
Bears Say
Very High LeverageDebt levels several times equity materially constrain financial flexibility. High leverage raises refinancing and interest-rate sensitivity, limits capacity for capex or acquisitions, and increases bankruptcy risk if cash flows weaken, making sustained operational improvement harder to translate into durable shareholder value.
Return To Net Losses And Negative ROERecent back-to-back net losses and negative ROE weaken the equity base and undermine reinvestment capacity. Persistent losses can force dilution or debt raises, erode stakeholder confidence, and make it difficult to sustain long-term strategic initiatives until profitability and ROE recover.
Volatile Free Cash FlowLarge swings in free cash flow reduce predictability for debt repayment, dividends, and investment. Even with positive operating cash flow, capex and working-capital variability have produced uneven cash conversion, complicating planning and hindering consistent deleveraging or growth investments over the medium term.
Eukedos S.p.A. News
EUK FAQ
What was Eukedos S.p.A.’s price range in the past 12 months?
Eukedos S.p.A. lowest stock price was €0.45 and its highest was €0.82 in the past 12 months.
What is Eukedos S.p.A.’s market cap?
Eukedos S.p.A.’s market cap is €13.08M.
When is Eukedos S.p.A.’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Eukedos S.p.A.’s earnings last quarter?
Currently, no data Available
Is Eukedos S.p.A. overvalued?
According to Wall Street analysts Eukedos S.p.A.’s price is currently Overvalued.
Does Eukedos S.p.A. pay dividends?
Eukedos S.p.A. pays a Notavailable dividend of €0.044 which represents an annual dividend yield of N/A. See more information on Eukedos S.p.A. dividends here
What is Eukedos S.p.A.’s EPS estimate?
Eukedos S.p.A.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Eukedos S.p.A. have?
Eukedos S.p.A. has 22,741,629 shares outstanding.
What happened to Eukedos S.p.A.’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Eukedos S.p.A.?
Currently, no hedge funds are holding shares in IT:EUK
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Eukedos S.p.A.
EuKedos S.p.A. operates in Italy, offering a range of managed and long-term care provisions. The company specializes in delivering residential social support for older adults, catering to both independent individuals and those needing extensive assistance. With 1,345 beds, it oversees healthcare and residential care facilities throughout northern and central Italy, notably in regions such as Lombardy, Piedmont, Abruzzo, Valle D'Aosta, and Emilia Romagna. EuKedos S.p.A. is headquartered in Florence, Italy.
Technical Analysis
Arterra Bioscience SpA
―
Farmacosmo S.P.A.
―
Svas Biosana S.p.A.
―
I.M.D. International Medical Devices S.P.A.
―
Piu Medical S.P.A.
―